• In June 2026, Synchrony Financial announced a partnership making its CareCredit card the preferred financing option across Pet Resort Hospitality Group’s 40 pet resort locations in 12 states, covering services such as daycare, grooming, boarding, training and supporting Pet Resort University’s professional education programs.
• This collaboration extends CareCredit’s use beyond veterinary clinics into everyday pet services, deepening Synchrony’s presence in the growing pet care financing segment and broadening its reach to thousands of pet owners who already rely on these resorts for comprehensive pet care.
• We’ll now examine how extending CareCredit into everyday pet services might influence Synchrony’s investment narrative and longer-term growth profile.

Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Synchrony Financial Investment Narrative Recap

To own Synchrony, you need to believe its partner-led credit model and disciplined underwriting can still grow receivables despite softer consumer spending and rising competition. The Pet Resort Hospitality Group deal modestly supports the near term growth catalyst in health and pet care financing, but does not change the key risk that purchase volumes and net revenue could stagnate if customers keep tightening spending or favor alternative payment options.

Among recent developments, the US$500 million fixed to floating rate perpetual preferred share offering stands out alongside the CareCredit expansion. While separate from pet financing, it highlights Synchrony’s focus on maintaining funding flexibility as it leans into higher growth verticals like health and pet services, a useful backdrop if credit conditions tighten or if new partnerships require additional balance sheet capacity.

Yet against this positive CareCredit momentum, investors should still be aware of how sustained pressure on purchase volumes and net revenue could...

Synchrony Financial’s narrative projects $16.6 billion revenue and $3.0 billion earnings by 2029.

Uncover how Synchrony Financial's forecasts yield a $89.22 fair value, a 22% upside to its current price.

Exploring Other Perspectives

While the CareCredit pet resort deal points to new revenue streams, the most pessimistic analysts still see profit margins falling toward 16.3 percent and earnings nearer US$2.7 billion, so it is worth comparing how their caution on weaker volumes and higher costs stacks up against this latest expansion.

Explore 7 other fair value estimates on Synchrony Financial - why the stock might be worth just $77.00!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Synchrony Financial research is our analysis highlighting 5 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Synchrony Financial research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synchrony Financial's overall financial health at a glance.

Want Some Alternatives?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Find 43 companies with promising cash flow potential yet trading below their fair value.
• Outshine the giants: these 14 early-stage AI stocks could fund your retirement.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.